Variable Total (n = 29) RVOT (n = 21) LVOT (n = 8) p-value
Age 47.6 ± 18.8 42.4 ± 16.6 61.1 ± 19.9 0.016
Male gender 16 (55.2%) 10 (47.6%) 6 (75.0%) NS
Ethnicity (Caucasian) 19/24 (79.2%) 13/17 (76.5%) 6/7 (85.7%) NS
Hypertension 5 (17.2%) 2 (9.5%) 3 (37.5%) NS
Diabetes 0 (0%) 0 (0%) 0 (0%) NS
Coronary disease 2 (6.9%) 1 (4.8%) 1 (12.5%) NS
BMI 26.9 ± 4.8 25.4 ± 4.8 28.1 ± 6.0 NS
LVEF % 54.7 ± 4.8 55.1 ± 4.9 45.9 ± 10.8 0.047
QRS morphology LBBB
Indeterminate
Atypical RBBB
27 (93.1%) 1 (3.4%) 1 (3.4%) 21 (100%) 0 (0%) 0 (0%) 6 (75.0%) 1 (12.5%) 1 (12.5%) NS NS NS
AAD Beta-blocker CCB Flecainide 20 (69.0%) 18 (62.1%) 1 (3.4%) 2 (6.9%) 13 (61.9%) 11 (52.4%) 1 (4.8%) 1 (4.8%) 7 (87.5%) 7 (88.5%) 0 (0%) 1 (12.5%) NS NS NS NS
Total VE burden 19.8% 18.6% 22.9% NS